Toboroz
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
NCT07787182· 1. fázis· Eli Lilly and Company· Forrás
Contact: Aaron Ellenbogen (principal investigator)
Még nem toboroz
A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)
NCT07843459· 1. fázis· Eli Lilly and Company· Forrás
Contact: Aaron Ellenbogen (principal investigator)
Toboroz
A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease
NCT07787169· 1. fázis· Eli Lilly and Company· Forrás
Contact: Aaron Ellenbogen (principal investigator)
Toboroz
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
NCT07005180· 2. fázis· Hillhurst Biopharmaceuticals, Inc.· Forrás
Contact: Tamsin Andres
Toboroz
A Study of LY3439539 in Participants With Alzheimer's Disease
NCT07598370· 1. fázis· Eli Lilly and Company· Forrás
Contact: Aaron Ellenbogen (principal investigator)
Toboroz
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
NCT07633470· 4. fázis· Alpha Cognition, Inc· Forrás
Contact: Aaron Ellenbogen
Toboroz
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
NCT07589595· 2. fázis· Eli Lilly and Company· Forrás
Contact: Aaron Ellenbogen (principal investigator)
Toboroz
Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
NCT07428447· CND Life Sciences· Forrás
Contact: Denise Morgott
Toboroz
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
NCT07422675· 1. fázis· Serina Therapeutics· Forrás
Contact: Heather Fasczewski
Toboroz
A Study of Buntanetap in Participants With PD
NCT07284784· 2/3. fázis· Annovis Bio Inc.· Forrás
Contact: Savannah Carra
Toboroz
A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)
NCT07280156· 2. fázis· Protalix· Forrás
Contact: Head of Clinical Development
Toboroz
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
NCT07174310· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
NCT07231419· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás
Fut, nem toboroz
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07170150· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
NCT06976203· 3. fázis· Bristol-Myers Squibb· Forrás
Contact: Aaron Ellenbogen, Site 0073
Toboroz
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
NCT07177352· 3. fázis· Hoffmann-La Roche· Forrás
Még nem toboroz
GyroGlove Use in Essential Tremor Patients
NCT05958030· GyroGear Ltd· Forrás
Contact: Peter LeWitt
Toboroz
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
NCT06937931· 2. fázis· Ipsen· Forrás
Contact: Ipsen Clinical Study Enquiries
Toboroz
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
NCT06944522· 3. fázis· BlueRock Therapeutics· Forrás
Contact: Patient Engagement
Toboroz
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
NCT07051629· 1. fázis· Suninflam Inc· Forrás
Contact: Aaron Ellenbogen, DO
Toboroz
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
NCT06735248· 2. fázis· ModernaTX, Inc.· Forrás
Contact: Moderna WeCare Team
Fut, nem toboroz
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease
NCT06773962· 2. fázis· TrueBinding, Inc.· Forrás
Toboroz
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
NCT06809400· 1. fázis· Eli Lilly and Company· Forrás
Contact: Aaron Ellenbogen (principal investigator)
Toboroz
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
NCT06765668· 4. fázis· Impax Laboratories, LLC· Forrás
Contact: Aaron Ellenbogen
Fut, nem toboroz
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
NCT06709014· 3. fázis· Annovis Bio Inc.· Forrás
Toboroz
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
NCT06680830· 2. fázis· Neuron23 Inc.· Forrás
Contact: Nancy Virdi
Fut, nem toboroz
Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease
NCT06747572· Vertex Pharmaceuticals Incorporated· Forrás
Toboroz
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
NCT06657768· 1. fázis· Eli Lilly and Company· Forrás
Contact: Aaron Ellenbogen (principal investigator)
Fut, nem toboroz
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
NCT06653153· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
NCT06584357· GAP Innovations, PBC· Forrás
Contact: Jorge Isunza
Fut, nem toboroz
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
NCT06553027· 3. fázis· Cerevance· Forrás
Fut, nem toboroz
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
NCT06544616· 2. fázis· Janssen Pharmaceutica N.V., Belgium· Forrás
Fut, nem toboroz
Parkinson's Disease Progression Study
NCT06219629· Koneksa Health· Forrás
Fut, nem toboroz
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults
NCT06047444· 3. fázis· Ipsen· Forrás
Fut, nem toboroz
GDNF Gene Therapy for Multiple System Atrophy
NCT04680065· 1. fázis· Brain Neurotherapy Bio, Inc.· Forrás
Fut, nem toboroz
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults
NCT06047457· 3. fázis· Ipsen· Forrás
Fut, nem toboroz
A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy
NCT05923866· 2. fázis· Ono Pharmaceutical Co., Ltd.· Forrás
Fut, nem toboroz
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT05696717· 3. fázis· Theravance Biopharma· Forrás
Fut, nem toboroz
A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
NCT05738486· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
NCT04777331· 2. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease
NCT04639050· 1/2. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
NCT04437511· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
NCT04006210· 3. fázis· NeuroDerm Ltd.· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease
NCT03100149· 2. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease
NCT02726386· 2. fázis· NeuroDerm Ltd.· Forrás